Keensight Capital acquired Symeres in 2021 Exemplify BioPharma provides integrated small molecule chemistry manufacturing and controls services to pharmaceutical and biotech partners Symeres is a ...
NIJMEGEN, Netherlands, Oct. 25, 2022 /PRNewswire/ -- Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), today ...
Symeres has acquired Exemplify BioPharma for an undisclosed price, marking the CRO and CDMO’s second purchase in the U.S. in 2022. In April, Netherlands-based Symeres snapped up U.S. lipid maker and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results